Effect of Anesthesia on Microelectrode Recordings during Deep Brain Stimulation Surgery in Tourette Syndrome Patients.


Journal

Stereotactic and functional neurosurgery
ISSN: 1423-0372
Titre abrégé: Stereotact Funct Neurosurg
Pays: Switzerland
ID NLM: 8902881

Informations de publication

Date de publication:
2019
Historique:
received: 26 03 2019
accepted: 25 09 2019
pubmed: 11 11 2019
medline: 1 4 2020
entrez: 11 11 2019
Statut: ppublish

Résumé

Deep brain stimulation (DBS) is an accepted treatment for patients with medication-resistant Tourette syndrome (TS). Sedation is commonly required during electrode implantation to attenuate anxiety, pain, and severe tics. Anesthetic agents potentially impair the quality of microelectrode recordings (MER). Little is known about the effect of these anesthetics on MER in patients with TS. We describe our experience with different sedative regimens on MER and tic severity in patients with TS. The clinical records of all TS patients who underwent DBS surgery between 2010 and 2018 were reviewed. Demographic data, stimulation targets, anesthetic agents, perioperative complications, and MER from each hemisphere were collected and analyzed. Single-unit activity was identified by filtering spiking activity from broadband MER data and principal component analysis with K-means clustering. Vocal and motor tics which caused artifacts in the MER data were manually selected using visual and auditory inspection. Six patients underwent bilateral DBS electrode implantation. In all patients, the target was the anterior internal globus pallidus. Patient comfort and hemodynamic and respiratory stability were maintained with conscious sedation with one or more of the following anesthetic drugs: propofol, midazolam, remifentanil, clonidine, and dexmedetomidine. Good quality MER and clinical testing were obtained in 9 hemispheres of 6 patients. In 3 patients, MER quality was poor on one side. Cautiously applied sedative drugs can provide patient comfort, hemodynamic and respiratory stability, and suppress severe tics, with minimal interference with MER.

Sections du résumé

BACKGROUND
Deep brain stimulation (DBS) is an accepted treatment for patients with medication-resistant Tourette syndrome (TS). Sedation is commonly required during electrode implantation to attenuate anxiety, pain, and severe tics. Anesthetic agents potentially impair the quality of microelectrode recordings (MER). Little is known about the effect of these anesthetics on MER in patients with TS. We describe our experience with different sedative regimens on MER and tic severity in patients with TS.
METHODS
The clinical records of all TS patients who underwent DBS surgery between 2010 and 2018 were reviewed. Demographic data, stimulation targets, anesthetic agents, perioperative complications, and MER from each hemisphere were collected and analyzed. Single-unit activity was identified by filtering spiking activity from broadband MER data and principal component analysis with K-means clustering. Vocal and motor tics which caused artifacts in the MER data were manually selected using visual and auditory inspection.
RESULTS
Six patients underwent bilateral DBS electrode implantation. In all patients, the target was the anterior internal globus pallidus. Patient comfort and hemodynamic and respiratory stability were maintained with conscious sedation with one or more of the following anesthetic drugs: propofol, midazolam, remifentanil, clonidine, and dexmedetomidine. Good quality MER and clinical testing were obtained in 9 hemispheres of 6 patients. In 3 patients, MER quality was poor on one side.
CONCLUSION
Cautiously applied sedative drugs can provide patient comfort, hemodynamic and respiratory stability, and suppress severe tics, with minimal interference with MER.

Identifiants

pubmed: 31707386
pii: 000503691
doi: 10.1159/000503691
pmc: PMC6979431
doi:

Substances chimiques

Anesthetics 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

225-231

Informations de copyright

© 2019 The Author(s) Published by S. Karger AG, Basel.

Références

Ann Neurol. 2003 Apr;53(4):480-8
pubmed: 12666115
Anesthesiology. 1991 Dec;75(6):1000-9
pubmed: 1660227
Brain. 2000 Mar;123 Pt 3:425-62
pubmed: 10686169
Eur J Neurosci. 2015 Aug;42(4):2070-7
pubmed: 26108432
J Neurosurg Anesthesiol. 2016 Jul;28(3):256-61
pubmed: 26083425
J Paediatr Child Health. 2018 Oct;54(10):1148-1153
pubmed: 30294996
Neurosurgery. 2005 Jul;57(1 Suppl):1-10; discussion 1-10
pubmed: 15987564
N Engl J Med. 2010 Dec 9;363(24):2332-8
pubmed: 21142535
Curr Opin Anaesthesiol. 2011 Oct;24(5):495-9
pubmed: 21772140
Eur J Neurosci. 2016 Dec;44(11):2909-2913
pubmed: 27717186
Neuromodulation. 2013 Sep-Oct;16(5):401-6; discussion 406
pubmed: 22780449
Brain Res. 2004 May 8;1007(1-2):109-15
pubmed: 15064141
JAMA Neurol. 2018 Mar 1;75(3):353-359
pubmed: 29340590
Brain. 2011 Mar;134(Pt 3):832-44
pubmed: 21354977
Clin Neurol Neurosurg. 2016 Mar;142:54-59
pubmed: 26811866
Pharmacol Biochem Behav. 1998 Jul;60(3):695-701
pubmed: 9678653
Anesthesiology. 2011 Aug;115(2):254-64
pubmed: 21701380
Mov Disord. 2008 Jul 15;23(9):1317-20
pubmed: 18442130
CNS Drugs. 2018 Jan;32(1):33-45
pubmed: 29335879
Neurosurgery. 2003 Jun;52(6):1358-70; discussion 1370-3
pubmed: 12762881
Curr Opin Anaesthesiol. 2015 Oct;28(5):505-10
pubmed: 26308514
Br J Anaesth. 2009 Aug;103(2):152-65
pubmed: 19556271
Neurosurgery. 2005 Apr;56(4):722-32; discussion 722-32
pubmed: 15792511
Clin Neurol Neurosurg. 2016 Apr;143:27-33
pubmed: 26895206
Anesth Analg. 2006 Nov;103(5):1224-8
pubmed: 17056959
World Neurosurg. 2016 May;89:320-8
pubmed: 26805677
J Psychiatry Neurosci. 1994 Jan;19(1):24-9
pubmed: 8148363
Nat Neurosci. 2016 Aug 26;19(9):1165-74
pubmed: 27571195
Adv Pharmacol. 2006;54:29-51
pubmed: 17175809
J Neurosci. 2006 Jun 14;26(24):6554-62
pubmed: 16775143
Anesth Analg. 2010 Nov;111(5):1285-9
pubmed: 20841416
World Neurosurg. 2017 Sep;105:526-528
pubmed: 28606582
J Neural Transm (Vienna). 2015 May;122(5):687-99
pubmed: 25081018
Brain Res. 1980 Apr 21;188(1):93-105
pubmed: 7370763
Anesth Analg. 2010 Apr 1;110(4):1138-45
pubmed: 20142347
Neurosci Lett. 2005 Oct 7;386(3):156-9
pubmed: 16024174
Neuromodulation. 2018 Feb;21(2):197-202
pubmed: 28102636

Auteurs

Michael J Bos (MJ)

Department of Anesthesiology and Pain Medicine, Maastricht University Medical Center, Maastricht, The Netherlands, michael.bos@mumc.nl.
School for Mental Health and Neuroscience, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands, michael.bos@mumc.nl.

Ana Maria Alzate Sanchez (AM)

School for Mental Health and Neuroscience, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands.
Department of Neurosurgery, Maastricht University Medical Center, Maastricht, The Netherlands.

Anouk Y J M Smeets (AYJM)

Department of Neurosurgery, Maastricht University Medical Center, Maastricht, The Netherlands.

Raffaella Bancone (R)

School for Mental Health and Neuroscience, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands.

Linda Ackermans (L)

School for Mental Health and Neuroscience, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands.
Department of Neurosurgery, Maastricht University Medical Center, Maastricht, The Netherlands.

Anthony R Absalom (AR)

Department of Anesthesiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

Wolfgang F Buhre (WF)

Department of Anesthesiology and Pain Medicine, Maastricht University Medical Center, Maastricht, The Netherlands.
School for Mental Health and Neuroscience, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands.

Mark J Roberts (MJ)

Department of Cognitive Neuroscience, Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, The Netherlands.

Marcus L F Janssen (MLF)

School for Mental Health and Neuroscience, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands.
Department of Neurology and Clinical Neurophysiology, Maastricht University Medical Center, Maastricht, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH